223 related articles for article (PubMed ID: 29928268)
1. A Small Molecule-Screening Pipeline to Evaluate the Therapeutic Potential of 2-Aminoimidazole Molecules Against
Thanissery R; Zeng D; Doyle RG; Theriot CM
Front Microbiol; 2018; 9():1206. PubMed ID: 29928268
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids.
Thanissery R; Winston JA; Theriot CM
Anaerobe; 2017 Jun; 45():86-100. PubMed ID: 28279860
[TBL] [Abstract][Full Text] [Related]
3. The microbial derived bile acid lithocholate and its epimers inhibit
Kisthardt SC; Thanissery R; Pike CM; Foley MH; Theriot CM
bioRxiv; 2023 Jun; ():. PubMed ID: 37333390
[TBL] [Abstract][Full Text] [Related]
4.
Deng H; Yang S; Zhang Y; Qian K; Zhang Z; Liu Y; Wang Y; Bai Y; Fan H; Zhao X; Zhi F
Front Microbiol; 2018; 9():2976. PubMed ID: 30619112
[No Abstract] [Full Text] [Related]
5. Functional Intestinal Bile Acid 7α-Dehydroxylation by
Studer N; Desharnais L; Beutler M; Brugiroux S; Terrazos MA; Menin L; Schürch CM; McCoy KD; Kuehne SA; Minton NP; Stecher B; Bernier-Latmani R; Hapfelmeier S
Front Cell Infect Microbiol; 2016; 6():191. PubMed ID: 28066726
[TBL] [Abstract][Full Text] [Related]
6. The Monoclonal Antitoxin Antibodies (Actoxumab-Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with
Džunková M; D'Auria G; Xu H; Huang J; Duan Y; Moya A; Kelly CP; Chen X
Front Cell Infect Microbiol; 2016; 6():119. PubMed ID: 27757389
[TBL] [Abstract][Full Text] [Related]
7. The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
Gunaratnam S; Diarra C; Paquette PD; Ship N; Millette M; Lacroix M
Probiotics Antimicrob Proteins; 2021 Aug; 13(4):949-956. PubMed ID: 33492661
[TBL] [Abstract][Full Text] [Related]
8. The
Wickramage I; Peng Z; Chakraborty S; Harmanus C; Kuijper EJ; Alrabaa S; Smits WK; Sun X
Microbiol Spectr; 2023 Jun; 11(3):e0377722. PubMed ID: 37125917
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection.
Crowther GS; Baines SD; Todhunter SL; Freeman J; Chilton CH; Wilcox MH
J Antimicrob Chemother; 2013 Jan; 68(1):168-76. PubMed ID: 22966180
[TBL] [Abstract][Full Text] [Related]
10. A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity.
Gebhart D; Lok S; Clare S; Tomas M; Stares M; Scholl D; Donskey CJ; Lawley TD; Govoni GR
mBio; 2015 Mar; 6(2):. PubMed ID: 25805733
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic-Induced Alterations of the Murine Gut Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile.
Schubert AM; Sinani H; Schloss PD
mBio; 2015 Jul; 6(4):e00974. PubMed ID: 26173701
[TBL] [Abstract][Full Text] [Related]
12.
Saenz C; Fang Q; Gnanasekaran T; Trammell SAJ; Buijink JA; Pisano P; Wierer M; Moens F; Lengger B; Brejnrod A; Arumugam M
Microbiol Spectr; 2023 Sep; 11(5):e0393322. PubMed ID: 37750706
[No Abstract] [Full Text] [Related]
13. Shifts in the Gut Metabolome and
Fletcher JR; Erwin S; Lanzas C; Theriot CM
mSphere; 2018; 3(2):. PubMed ID: 29600278
[TBL] [Abstract][Full Text] [Related]
14. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
Collins DA; Riley TV
Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124
[TBL] [Abstract][Full Text] [Related]
15. Sub-lethal doses of surotomycin and vancomycin have similar effects on Clostridium difficile virulence factor production in vitro.
Aldape MJ; Rice SN; Field KP; Bryant AE; Stevens DL
J Med Microbiol; 2018 Dec; 67(12):1689-1697. PubMed ID: 30307842
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial Activity of Tannic Acid
Wang W; Cao J; Yang J; Niu X; Liu X; Zhai Y; Qiang C; Niu Y; Li Z; Dong N; Wen B; Ouyang Z; Zhang Y; Li J; Zhao M; Zhao J
Microbiol Spectr; 2023 Feb; 11(1):e0261822. PubMed ID: 36537806
[TBL] [Abstract][Full Text] [Related]
17. Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria.
Passmore IJ; Letertre MPM; Preston MD; Bianconi I; Harrison MA; Nasher F; Kaur H; Hong HA; Baines SD; Cutting SM; Swann JR; Wren BW; Dawson LF
PLoS Pathog; 2018 Sep; 14(9):e1007191. PubMed ID: 30208103
[TBL] [Abstract][Full Text] [Related]
18. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
[TBL] [Abstract][Full Text] [Related]
19.
Schäffler H; Breitrück A
Front Microbiol; 2018; 9():646. PubMed ID: 29692762
[No Abstract] [Full Text] [Related]
20.
Jenior ML; Leslie JL; Young VB; Schloss PD
mSystems; 2017; 2(4):. PubMed ID: 28761936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
